Role of primary prophylaxis for pneumocystis pneumonia in patients treated with systemic corticosteroids or other immunosuppressive agents for immune-mediated dermatologic conditions-Reference-Cited by-同舟云学术

Role of primary prophylaxis for pneumocystis pneumonia in patients treated with systemic corticosteroids or other immunosuppressive agents for immune-mediated dermatologic conditions

Published:2010-11 Issue:5 Volume:63 Page:815-823
ISSN:0190-9622
Container-title:Journal of the American Academy of Dermatology
language:en
Short-container-title:Journal of the American Academy of Dermatology

Author:

Lehman Julia S.,Kalaaji Amer N.

Publisher

Elsevier BV

Subject

Dermatology

Reference45 articles.

1. Pulmonary complications of combination therapy with cyclophosphamide and prednisone;Sen;Chest,1991

2. Pneumocystis carinii pneumonia in the course of connective tissue disease: report of 34 cases;Godeau;J Rheumatol,1994

3. Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome: associated illness and prior corticosteroid therapy;Yale;Mayo Clin Proc,1996

4. Pneumocystis jiroveci pneumonia in patients with rheumatoid arthritis treated with infliximab: a retrospective review and case-control study of 21 patients;Komano;Arthritis Rheum,2009

5. Pneumocystis carinii pneumonia complicating methotrexate treatment of pityriasis rubra pilaris;Duncan;J Am Acad Dermatol,1998

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictive Modeling of Pneumonia-Related Mortality in Long-Term Immunosuppressive Therapy Patients: A Machine Learning Approach with Interpretability;2024-03-13

2. Orbitopatía tiroidea. Puntos clave para el diagnóstico y tratamiento;Revista ORL;2023-07-26

3. Rapidly progressive interstitial lung disease combined with pneumocystis jiroveci pneumonia in a patient with single anti-TIF-1γ antibody positive dermatomyositis in the context of an underlying tumor;BMC Pulmonary Medicine;2023-07-06

4. Cotrimoxazole as a Preventative Intervention for Pneumocystis Pneumonia in Pemphigus Patients Treated with Rituximab: A Retrospective Study;Dermatology and Therapy;2023-06-15

5. Retrospective analysis of risks and benefits of trimethoprim/sulfamethoxazole as prophylaxis for Pneumocystis jiroveci pneumonia in patients with dermatologic disease;Journal of the American Academy of Dermatology;2023-06